Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amir Avan

Showing results (101-110 of 462) with videos related to

Pageof 47
Sort By:
Current Cancer Drug Targets|May 19, 2022
Angiotensin-converting Enzyme Inhibitors and Angiotensin Receptor Blockers as Potential Therapeutic Options for Pancreatic CancerFereshteh Asgharzadeh, Kiarash Roustai Geraylow, Majid Khazaei, et al.
Journal of Cancer Research and Clinical Oncology|June 12, 2021
Anticancer activity of Helicobacter pylori ribosomal protein (HPRP) with iRGD in treatment of colon cancerAtieh Yaghoubi, Fereshteh Asgharzadeh, Aref Movaqar, et al.
Toxicology and Applied Pharmacology|May 15, 2021
Delivery of oxaliplatin to colorectal cancer cells by folate-targeted UiO-66-NH<sub>2</sub>Alireza Hashemzadeh, Forouzan Amerizadeh, Fereshteh Asgharzadeh, et al.
Current Pharmaceutical Design|October 10, 2024
Evaluating the Therapeutic Efficacy of <i>Lactobacillus</i> Strains in the Management of Ulcerative Colitis: An Overview of Recent AdvancesShaghayegh Rezaei, Elnaz Ghorbani, Abdulridha Mohammed Al-Asady, et al.
Journal of Cellular Biochemistry|May 26, 2017
Genetic Background of Hirschsprung Disease: A Bridge Between Basic Science and Clinical ApplicationAfsane Bahrami, Marjan Joodi, Mehrdad Moetamani-Ahmadi, et al.
Cancers|September 10, 2021
Cyclin Dependent Kinase-1 (CDK-1) Inhibition as a Novel Therapeutic Strategy against Pancreatic Ductal Adenocarcinoma (PDAC)Rosa Wijnen, Camilla Pecoraro, Daniela Carbone, et al.
Journal of Cellular Physiology|August 28, 2018
Therapeutic potential of A2 adenosine receptor pharmacological regulators in the treatment of cardiovascular diseases, recent progress, and prospectiveAmirhossein Bahreyni, Amir Avan, Mohammad Shabani, et al.
Nephrology (Carlton, Vic.)|November 19, 2016
Pimpinella anisum L. ethanolic extract ameliorates the gentamicin- induced nephrotoxicity in ratsSaeed Changizi-Ashtiyani, Amirhassan Seddigh, Houshang Najafi, et al.
Journal of Cellular Physiology|November 19, 2017
Toll like receptor signaling pathway as a potential therapeutic target in colorectal cancerReyhaneh Moradi-Marjaneh, Seyed Mahdi Hassanian, Hamid Fiuji, et al.
Current Pharmaceutical Design|January 15, 2019
The Esophageal Cancer and the PI3K/AKT/mTOR Signaling Regulatory microRNAs: a Novel Marker for Prognosis, and a Possible Target for ImmunotherapySeyed A Javadinia, Soodabeh Shahidsales, Azar Fanipakdel, et al.
Pageof 47

Showing results (101-110 of 462) with videos related to

Sort By:
Pageof 47
Current Cancer Drug Targets|May 19, 2022
Angiotensin-converting Enzyme Inhibitors and Angiotensin Receptor Blockers as Potential Therapeutic Options for Pancreatic CancerFereshteh Asgharzadeh, Kiarash Roustai Geraylow, Majid Khazaei, et al.
Journal of Cancer Research and Clinical Oncology|June 12, 2021
Anticancer activity of Helicobacter pylori ribosomal protein (HPRP) with iRGD in treatment of colon cancerAtieh Yaghoubi, Fereshteh Asgharzadeh, Aref Movaqar, et al.
Toxicology and Applied Pharmacology|May 15, 2021
Delivery of oxaliplatin to colorectal cancer cells by folate-targeted UiO-66-NH<sub>2</sub>Alireza Hashemzadeh, Forouzan Amerizadeh, Fereshteh Asgharzadeh, et al.
Current Pharmaceutical Design|October 10, 2024
Evaluating the Therapeutic Efficacy of <i>Lactobacillus</i> Strains in the Management of Ulcerative Colitis: An Overview of Recent AdvancesShaghayegh Rezaei, Elnaz Ghorbani, Abdulridha Mohammed Al-Asady, et al.
Journal of Cellular Biochemistry|May 26, 2017
Genetic Background of Hirschsprung Disease: A Bridge Between Basic Science and Clinical ApplicationAfsane Bahrami, Marjan Joodi, Mehrdad Moetamani-Ahmadi, et al.
Cancers|September 10, 2021
Cyclin Dependent Kinase-1 (CDK-1) Inhibition as a Novel Therapeutic Strategy against Pancreatic Ductal Adenocarcinoma (PDAC)Rosa Wijnen, Camilla Pecoraro, Daniela Carbone, et al.
Journal of Cellular Physiology|August 28, 2018
Therapeutic potential of A2 adenosine receptor pharmacological regulators in the treatment of cardiovascular diseases, recent progress, and prospectiveAmirhossein Bahreyni, Amir Avan, Mohammad Shabani, et al.
Nephrology (Carlton, Vic.)|November 19, 2016
Pimpinella anisum L. ethanolic extract ameliorates the gentamicin- induced nephrotoxicity in ratsSaeed Changizi-Ashtiyani, Amirhassan Seddigh, Houshang Najafi, et al.
Journal of Cellular Physiology|November 19, 2017
Toll like receptor signaling pathway as a potential therapeutic target in colorectal cancerReyhaneh Moradi-Marjaneh, Seyed Mahdi Hassanian, Hamid Fiuji, et al.
Current Pharmaceutical Design|January 15, 2019
The Esophageal Cancer and the PI3K/AKT/mTOR Signaling Regulatory microRNAs: a Novel Marker for Prognosis, and a Possible Target for ImmunotherapySeyed A Javadinia, Soodabeh Shahidsales, Azar Fanipakdel, et al.
Pageof 47